Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by IL22RA2 is a soluble class II cytokine receptor. Additionally we are shipping IL22RA2 Kits (16) and IL22RA2 Proteins (14) and many more products for this protein.
Showing 10 out of 74 products:
Human Polyclonal IL22RA2 Primary Antibody for IHC, IHC (p) - ABIN4324964
Laaksonen, Guerreiro-Cacais, Adzemovic, Parsa, Zeitelhofer, Jagodic, Olsson: The multiple sclerosis risk gene IL22RA2 contributes to a more severe murine autoimmune neuroinflammation. in Genes and immunity 2014
Show all 2 references for ABIN4324964
Human Polyclonal IL22RA2 Primary Antibody for ELISA - ABIN1997995
Whittington, Armstrong, Uppington, Millar: Interleukin-22: a potential immunomodulatory molecule in the lung. in American journal of respiratory cell and molecular biology 2004
thia study shows shows that nonaffected skin of psoriasis patients displays lower expression of IL-22BP than skin of healthy controls, and that the strong IL-22 (show IL22 Antibodies) increase in lesional psoriatic skin is accompanied by a moderate induction of IL-22BP
The deletion of IFNGR1 (show IFNGR1 Antibodies) causes complete IFN-gammaR1 deficiency. Despite the deletion ending very close to the IL22RA2 gene, it does not appear to affect IL22RA2 transcription.
IL-22BP is produced by eosinophils in the gut (show GUSB Antibodies) and blocks IL-22 (show IL22 Antibodies) protective actions in colitis.
Through a combined approach including genetic and immunological investigation in an animal model and large-scale association studies of patients with multiple sclerosis (MS), IL-22RA2 is established as an MS risk gene.
The IL-22R (show IL22RA1 Antibodies) and IL-10R2 (show IL10RB Antibodies) binding sites are juxtaposed on adjacent IL-22 (show IL22 Antibodies) surfaces contributed mostly by helices A, D, and F and loop AB.
Crystallization and preliminary X-ray diffraction results of the IL-22-IL-22 (show IL22 Antibodies) binding protein (IL-22BP) complex are described.
Comparison of IL-22 (show IL22 Antibodies)/IL-22BP and IL-22 (show IL22 Antibodies)/IL-22R1 crystal structures shows that both receptors display an overlapping IL-22 (show IL22 Antibodies) binding surface, which is consistent with the inhibitory role played by IL-22 (show IL22 Antibodies) binding protein.
Polymorphisms in IL22RA1 (show IL22RA1 Antibodies) are associated with severe CRS (show CARS Antibodies).
IL22RA2 KO displayed a less severe EAE course, less demyelination and less infiltration of immune cells in the CNS.
the IL-22 (show IL22 Antibodies)-IL-22BP axis critically regulates intestinal tissue repair and tumorigenesis in the colon
cloning and characterization; gene encodes a protein of 230 amino acids that share 67.1% amino-acid sequence identity with human IL-22 (show IL22 Antibodies) binding protein; upregulated by LPS (show TLR4 Antibodies) stimulation in monocytes
The protein encoded by this gene is a soluble class II cytokine receptor. This protein has been shown to specifically bind to interleukin 22 (IL22), block the interaction of IL22 with its cell surface receptor, and thus inhibit IL22 activity. This protein functions as an IL22 antagonist, and may be important in the regulation of inflammatory response. Three alternatively spliced transcript variants encoding distinct isoforms have been described.
interleukin 22-binding protein
, interleukin 22 receptor, alpha 2
, interleukin 22-binding protein-like
, cytokine receptor class-II member 10
, cytokine receptor family type 2, soluble 1
, interleukin-22 receptor subunit alpha-2
, IL-22 receptor subunit alpha-2
, cytokine receptor family II soluble 1
, interleukin-22-binding protein